Morgan Stanley
CLOV icon

Morgan Stanley’s Clover Health Investments CLOV Stock Holding History

Morgan Stanley’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
2,294,305
+107,881
+5% +$366K ﹤0.01% 3547
2026
Q1 		$3.85M Sell
2,186,424
-412,604
-16% -$895K ﹤0.01% 4324
2025
Q4 		$6.11M Buy
2,599,028
+585,627
+29% +$1.6M ﹤0.01% 4032
2025
Q3 		$6.16M Sell
2,013,401
-1,384,770
-41% -$3.96M ﹤0.01% 3978
2025
Q2 		$9.48M Buy
3,398,171
+1,165,916
+52% +$3.83M ﹤0.01% 3493
2025
Q1 		$8.01M Buy
2,232,255
+649,786
+41% +$2.61M ﹤0.01% 3540
2024
Q4 		$4.98M Buy
1,582,469
+68,246
+5% +$244K ﹤0.01% 4001
2024
Q3 		$4.27M Buy
1,514,223
+326,101
+27% +$746K ﹤0.01% 4082
2024
Q2 		$1.46M Buy
1,188,122
+403,650
+51% +$362K ﹤0.01% 4753
2024
Q1 		$623K Sell
784,472
-30,168
-4% -$27.4K ﹤0.01% 5210
2023
Q4 		$776K Sell
814,640
-332,656
-29% -$327K ﹤0.01% 5080
2023
Q3 		$1.24M Sell
1,147,296
-517,357
-31% -$616K ﹤0.01% 4674
2023
Q2 		$1.49M Buy
1,664,653
+476,570
+40% +$423K ﹤0.01% 4603
2023
Q1 		$1M Buy
1,188,083
+125,489
+12% +$137K ﹤0.01% 4855
2022
Q4 		$988K Sell
1,062,594
-331,476
-24% -$442K ﹤0.01% 4877
2022
Q3 		$2.37M Buy
1,394,070
+150,518
+12% +$394K ﹤0.01% 4304
2022
Q2 		$2.66M Sell
1,243,552
-142,580
-10% -$379K ﹤0.01% 4314
2022
Q1 		$4.92M Sell
1,386,132
-615,657
-31% -$1.79M ﹤0.01% 3703
2021
Q4 		$7.45M Buy
2,001,789
+335,557
+20% +$2.06M ﹤0.01% 3288
2021
Q3 		$12.3M Buy
1,666,232
+844,347
+103% +$7.22M ﹤0.01% 2649
2021
Q2 		$10.9M Buy
821,885
+705,532
+606% +$6.93M ﹤0.01% 2870
2021
Q1 		$879K Sell
116,353
-337,410
-74% -$3.81M ﹤0.01% 4815
2020
Q4 		$7.61M Buy
453,763
+128,511
+40% +$1.43M ﹤0.01% 2807
2020
Q3 		$4.05M Buy
+325,252
New +$3.6M ﹤0.01% 2917

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley's CLOV Position: Q2 2026 in Review

Morgan Stanley increased its Clover Health Investments (CLOV) stake by 4.9% in Q2 2026, buying an estimated $366K and bringing the position to 2,294,305 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #3547.

Morgan Stanley first reported a position in CLOV in Q3 2020 and has held it in 24 quarters since. The position peaked at $12.3M in Q3 2021. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Morgan Stanley held 2,294,305 shares of Clover Health Investments worth $12M as of Q2 2026.
  • Morgan Stanley bought 107,881 Clover Health Investments shares in Q2 2026, an estimated $366K.
  • Clover Health Investments made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3547 holding.
  • Morgan Stanley first reported a position in Clover Health Investments in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's Clover Health Investments position peaked at $12.3M in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.